Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

solitary fibrous tumor (SFT) - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

solitary fibrous tumor

MONDO:0016238

Also known as:SFTlocalised fibrous mesotheliomalocalised fibrous tumour

Find Clinical TrialsTrials

Overview

Solitary fibrous tumor (SFT) represents a diverse group of ubiquitous rare spindle cell neoplasms that may be benign or malignant and that most frequently arises from the pleura and peritoneum and rarely from other sites such as head and neck, liver and skeletal muscle. SFT may be clinically asymptomatic or may present with enlarging mass, compressive effects depending on the site involved and rarely with paraneoplastic manifestations (osteoarthropathy or hypoglycemia).

Clinical Trials5 registered · 2 recruiting

Diagnosis

Biomarker and diagnostic research for solitary fibrous tumor has been reported in the published literature.

Prognosis

Estimated prevalence: Unknown (Unknown prevalence).

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

5 clinical trials registered, 2 recruiting. Interventions under study include other interventions, drug therapy, and procedural interventions. Pipeline includes 2 PHASE1, 1 NA. Research is sponsored by a mix of industry and academic institutions.

NCT ID	Title	Phase	Sponsor	Status
[NCT05259605](https://clinicaltrials.gov/study/NCT05259605)

Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 5:31 PM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

External Resources

Orphanet

European rare disease database

Orphanet:2126

GARD

Genetic and Rare Diseases Info Center

GARD:15014

Questions for Your Care Team

→Are any of the 5 active clinical trials a good fit for my situation?
→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

Research Type	Count	% of Total
Patient case studies	156	63%
Research summaries	29	12%
Testing and diagnosis research	23	9%
Laboratory research	13	5%
Clinical study results	10	4%
Disease patterns and progression	9	4%
Other research	5	2%
New treatment approaches	2	1%

Kisho

solitary fibrous tumor

Overview

Diagnosis

Prognosis

Research Landscape

Medical References

External Resources

Orphanet

GARD

Questions for Your Care Team

Questions for Your Care Team

Recent Publications

Latest News & Developments

Solitary Fibrous Tumors Involving the Prostate and Periprostatic Region A Multi-Institutional Cohort of 33 Cases with Literature Review.

Solitary Fibrous Tumor Generated From Uterine Corpus With Doege-Potter Syndrome in Primary Disease: A Rare Case of Recurrent Disease Without Hypoglycemia.

Systemic Therapy for Solitary Fibrous Tumor.

solitary fibrous tumor

Overview

Diagnosis

Prognosis

Research Landscape

Medical References

External Resources

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

Recent Publications

Latest News & Developments

Solitary Fibrous Tumors Involving the Prostate and Periprostatic Region A Multi-Institutional Cohort of 33 Cases with Literature Review.

Solitary Fibrous Tumor Generated From Uterine Corpus With Doege-Potter Syndrome in Primary Disease: A Rare Case of Recurrent Disease Without Hypoglycemia.

Systemic Therapy for Solitary Fibrous Tumor.